Austin

Invisible Ink Tattoo Removers Opening New Studio in Greater Cincinnati

Retrieved on: 
Tuesday, September 3, 2019

CINCINNATI, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Invisible Ink Tattoo Removers, the worlds leading specialty provider of tattoo removal, fade and change services, celebrates the grand opening of its newest studio on Thursday, September 12 to serve greater Cincinnati.

Key Points: 
  • CINCINNATI, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Invisible Ink Tattoo Removers, the worlds leading specialty provider of tattoo removal, fade and change services, celebrates the grand opening of its newest studio on Thursday, September 12 to serve greater Cincinnati.
  • With more than 70,000 successful treatments completed, Invisible Ink Tattoo Removers is the world's leading specialty provider of tattoo removal, fade and change services.
  • Using innovative PicoWay laser technology, Invisible Ink Tattoo Removers is on the cutting edge of tattoo removal science and technology.
  • Invisible Ink Tattoo Removers helps people change with integrity, lasting relationships, the latest in science and technology and zero judgments.

Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium

Retrieved on: 
Tuesday, September 3, 2019
Arginase, Urea cycle, ARG1

Im very encouraged by the improvements in mobility we observed in these patients after 20 doses.

Key Points: 
  • Im very encouraged by the improvements in mobility we observed in these patients after 20 doses.
  • Additionally, Aeglea announced that 10 patients have been dosed subcutaneously (sc) with pegzilarginase in the ongoing OLE trial in patients with ARG1-D.
  • Aegleas Phase 1/2 and Phase 2 open-label extension data evaluating pegzilarginase in patients with Arginase 1 Deficiency demonstrated clinical improvements and sustained lowering of plasma arginine.
  • Aeglea is developing pegzilarginase, its lead product candidate, for the treatment of Arginase 1 Deficiency which has received both Rare Pediatric Disease and Breakthrough Therapy Designation.

Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference

Retrieved on: 
Tuesday, September 3, 2019
Branches of biology, Biology, Organ systems, Neuroscience, Dementia, Neurodegeneration, Senescence, Alzheimer's disease, Protein folding

It will also be available for replay for 90 days following the conference on CassavaSciences.com in the Investors section.

Key Points: 
  • It will also be available for replay for 90 days following the conference on CassavaSciences.com in the Investors section.
  • PTI-125 has a novel mechanism of action: it stabilizes a critical, and misfolded, protein in the brain.
  • Our Phase 2a was a U.S., multi-center, open-label study of PTI-125 in thirteen patients with mild-to-moderate Alzheimers disease.
  • The mission of Cassava Sciences is to detect and treat neurodegenerative diseases, such as Alzheimers disease.

Legal Tech Solutions Leader, Mitratech Advances Client Co-innovation at Interact 2019

Retrieved on: 
Tuesday, September 3, 2019
Information technology management, Business process management, Workflow

AUSTIN, Texas, Sept. 03, 2019 (GLOBE NEWSWIRE) -- The leader in legal management solutions, Mitratech, is pleased to announce TeamConnect 6.2 and new enhancements to the TAP Co-Innovation Center in conjunction with the companys annual customer event Interact 2019 .

Key Points: 
  • AUSTIN, Texas, Sept. 03, 2019 (GLOBE NEWSWIRE) -- The leader in legal management solutions, Mitratech, is pleased to announce TeamConnect 6.2 and new enhancements to the TAP Co-Innovation Center in conjunction with the companys annual customer event Interact 2019 .
  • TAP Workflow Automation empowers Mitratech customers to automate nearly any repetitive manual legal, compliance or risk process, enhancing their agility and responsiveness, improving performance and compliance, and accelerating ROI.
  • Some of the many examples of workflows include legal matter intake, contract requests, self-service NDAs, and conflict of interest reporting.
  • Our new General Counsel dashboard will be especially helpful in creating visibility around legal spend forecasting for the department.

NXP Semiconductors Announces Increase of Quarterly Dividend

Retrieved on: 
Thursday, August 29, 2019
Private equity, Finance, Eindhoven, NXP Semiconductors, Philips, Dividends, Taxation in Australia

EINDHOVEN, The Netherlands, Aug. 29, 2019 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that, as part of the Quarterly Dividend Program, its board of directors has approved the payment of interim dividend for the third quarter of 2019 of $ 0.375 per ordinary share, reflecting an increase of 50% from the prior quarterly dividends.

Key Points: 
  • EINDHOVEN, The Netherlands, Aug. 29, 2019 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that, as part of the Quarterly Dividend Program, its board of directors has approved the payment of interim dividend for the third quarter of 2019 of $ 0.375 per ordinary share, reflecting an increase of 50% from the prior quarterly dividends.
  • The interim dividend will be paid on October 4, 2019 to shareholders of record on September 16, 2019.
  • Non-Dutch resident shareholders, depending on their circumstances, may be entitled to a full or partial refund of Dutch dividend withholding tax.
  • NXP Semiconductors N.V. (NASDAQ: NXPI) enables secure connections for a smarter world, advancing solutions that make lives easier, better, and safer.

Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium

Retrieved on: 
Thursday, August 29, 2019
Urea cycle, Arginase

SSIEM Poster and E-poster Presentations at De Doelen, Rotterdam, the Netherlands

Key Points: 
  • SSIEM Poster and E-poster Presentations at De Doelen, Rotterdam, the Netherlands
    Lead Author: George A. Diaz, M.D., Ph.D., Icahn School of Medicine at Mt.
  • Aeglea will hold a conference call on Tuesday, September 3, 2019 at 9:00 a.m.
  • Aegleas Phase 1/2 and Phase 2 open-label extension data evaluating pegzilarginase in patients with Arginase 1 Deficiency demonstrated clinical improvements and sustained lowering of plasma arginine.
  • Aeglea is developing pegzilarginase, its lead product candidate, for the treatment of Arginase 1 Deficiency which has received both Rare Pediatric Disease and Breakthrough Therapy Designation.

Four SolarWinds Solutions Named 2019 Top Rated Products by TrustRadius

Retrieved on: 
Thursday, August 29, 2019
System administration, Information technology management, Network management, Software, Computing, Cross-platform software, SolarWinds, Npm, Application performance management, Npm

TrustRadius Top Rated Product distinctions are particularly important for us because theyre entirely based on end-user reviews the only feedback that really matters, said Craig McDonald, vice president, product, SolarWinds.

Key Points: 
  • TrustRadius Top Rated Product distinctions are particularly important for us because theyre entirely based on end-user reviews the only feedback that really matters, said Craig McDonald, vice president, product, SolarWinds.
  • The SolarWinds solutions were named Top Rated products in each of their respective categories:
    SolarWinds SAM won in Application Performance Management (APM): TrustRadius reviews from verified users show 8.3 out of 10 users are likely to recommend SAM, with 9.0 out of 10 likely to renew.
  • Along with SolarWinds NPM, three SolarWinds Systems Management productsSAM, DPA, and VMANtake the top honors in their respective TrustRadius categories.
  • "SolarWinds Database Performance Analyzer, SolarWinds Server & Application Monitor, SolarWinds NPM, and SolarWinds Virtualization Manager have won a Top-Rated Award for SolarWinds based entirely on feedback from their customers," said Megan Headley, VP of Research at TrustRadius.

Enverus Boosts its Collection of World-Class Geology Solutions with Reservoir Visualization, Inc.

Retrieved on: 
Wednesday, August 28, 2019
Natural gas, Petroleum production, Petroleum industry, Fuels, Energy, Oil refining, Midstream, Oil storage, Downstream, Upstream, Oil well

The expansion quadruples Enverus interpreted well log catalog and is the first announcement since the company changed its name from Drillinginfo earlier this month.

Key Points: 
  • The expansion quadruples Enverus interpreted well log catalog and is the first announcement since the company changed its name from Drillinginfo earlier this month.
  • As just one example, more landing zones and wellbore statistics of higher precision will expand Enverus geographical areas of coverage.
  • Not all data are created equal, noted Jimmy Fortuna, Senior Vice President of Products at Enverus.
  • Enverus solutions deliver value across upstream, midstream and downstream sectors, enabling the industry to be more collaborative, efficient and competitive.

AI Global Welcomes Ashley Casovan as its New Executive Director

Retrieved on: 
Wednesday, August 28, 2019
Articles, Emerging technologies, Technology, Artificial intelligence, Computational neuroscience, Cybernetics, Academic disciplines

AUSTIN, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- AI Global , a nonprofit organization focused on advancing responsible and ethical adoption of artificial intelligence (AI), is pleased to welcome Ashley Casovan as our new Executive Director.

Key Points: 
  • AUSTIN, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- AI Global , a nonprofit organization focused on advancing responsible and ethical adoption of artificial intelligence (AI), is pleased to welcome Ashley Casovan as our new Executive Director.
  • "I am excited to join AI Global at such an important time in history, Ashley said.
  • AI Global is a nonprofit organization focused on putting research into action by creating tangible tools to help accelerate the design, development, and use of Responsible AI.
  • Founded in 2017 by the University of Texas, USAA, and CognitiveScale, AI Global works to both expand opportunities and minimize harm in local and global communities.

Bazaarvoice Acquires Influenster to Enhance Product Reviews and User-Generated Content Solutions

Retrieved on: 
Wednesday, August 28, 2019
Marketing, Market economics), Microeconomics, Review websites, Bazaarvoice, Brand management, Procter & Gamble, User-generated content, Brand, Influenster, Word-of-mouth marketing, Coty, Inc.

AUSTIN, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Bazaarvoice, Inc., the leading provider of product reviews and user-generated content (UGC) solutions, today announced it has acquired Influenster, a product discovery and reviews platform with nearly six million community members worldwide.

Key Points: 
  • AUSTIN, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Bazaarvoice, Inc., the leading provider of product reviews and user-generated content (UGC) solutions, today announced it has acquired Influenster, a product discovery and reviews platform with nearly six million community members worldwide.
  • Through the combined solutions of Bazaarvoice and Influenster, brands will have a single partner to help them build relationships with new and existing customers, create a comprehensive product reviews and UGC strategy, and power word-of-mouth marketing at scale.
  • Brands including Coty and Procter & Gamble work with Influenster to run product sampling campaigns, generate and license organic review and social content, and build brand awareness.
  • The platform has more than 38 million product reviews, growing by one million monthly, written by nearly six million members.